## Abstract Our purpose was to characterize a state of mild cognitive impairment (MCI) in Parkinson's disease (PD) (PDβMCI) that would be analogous to the MCI that is posited as a precursor of Alzheimer's disease (AD). We categorized 86 PD subjects in a brain bank population as either cognitively n
Characterizing mild cognitive impairment in Parkinson's disease
β Scribed by John C. Dalrymple-Alford; Leslie Livingston; Michael R. MacAskill; Charlotte Graham; Tracy R. Melzer; Richard J. Porter; Richard Watts; Tim J. Anderson
- Publisher
- John Wiley and Sons
- Year
- 2011
- Tongue
- English
- Weight
- 343 KB
- Volume
- 26
- Category
- Article
- ISSN
- 0885-3185
No coin nor oath required. For personal study only.
β¦ Synopsis
Abstract
There is growing interest in identifying Parkinson's disease (PD) patients with mild cognitive impairment (PDβMCI), but widely disparate criteria have been used. We assessed 143 PD patients and 50 matched controls on 20 measures across 4 cognitive domains (executive function, attention and working memory, learning and memory, visuoperception). Twentyβfour patients met criteria for dementia (PDβD); nondementia patients were classified as either with normal cognition or MCI for 12 neuropsychological criteria. We compared the influence of these criteria on the distribution of global cognitive performance in the resulting PDβMCI groups relative to the control and PDβD groups. Different criteria produced substantial variation in the proportion of PDβMCI cases identified. Fourteen percent PDβMCI was found when using 2 scores in 1 domain at 2 standard deviations (SD) below normative scores, with no controls identified as MCI, through to 89% PDβMCI with 1 score in 1 domain at 1 SD below normative scores, when 70% of controls were identified as MCI. The balance of cases with impaired cognition but not those with generally intact cognition was better served by using criteria that required 2 specific deficit scores or deficits across 2 domains. As comparisons with external normative data may have greater applicability across centers, we suggest that 2 scores at β1.5 SD within any single domain (30% PDβMCI) or 1 score at β1.5 SD in each of 2 domains (37% PDβMCI) provide suitable criteria to minimize the inclusion of cognitively well patients. Clinical dementia rating did not improve the relative identification of cognitively impaired and unimpaired nondementia PD patients. Β© 2011 Movement Disorder Society
π SIMILAR VOLUMES
Mild cognitive impairment (MCI) may predict future development of dementia in Parkinson's disease (PD). We aimed to examine the extent of subcortical brain atrophy in patients with early PD with and without MCI compared to normal controls (NC). Participating in a population-based study were 43 early
## Abstract A substantial percentage of patients with newly diagnosed Parkinson's disease without dementia are reported to be affected by cognitive impairment (CI). In practice, however, CI is underrecognized, as the signs may not be apparent in earlyβstage disease and many routine assessment tools
## Abstract The aim of this study was to establish the rate of progression from mild cognitive impairment (MCI) to dementia in patients with Parkinson's disease (PD). PD patients without dementia were recruited in 1997 from an ongoing prospective epidemiological study. The assessment included neuro
## Abstract Patients with Parkinson's disease (PD) may present impairment in cognitive functions even at early stages of the disease. When compared with the general population, their risk of dementia is five to six times higher. Recent investigations using structural MRI have shown that dementia in
## Abstract Over the last decade, the importance of cognitive impairment and dementia in Parkinson's disease (PDD) has been increasingly recognized. Investigators have proposed criteria for PD dementia, and mild cognitive impairment. Risk profiles associated with the development of dementia based o